HKEX reported its 1QFY2025 results on April 30, posting record quarterly revenue of HK$6.9 billion, up 32% y-o-y; and record ...

The deal, valued at over 5.73 trillion VND (about 220.6 million USD), underscores the increasing attractiveness of Vietnam's ...

While MIC2025 was officially shelved from public discourse in 2018 due to intense international backlash, its core objectives ...

Pharmacist Steve Mitchell with Circle Drug on Robinson Drive in Waco talks on what can potentially happen with the costs of your prescription drugs as tariffs loom.

This monthly report outlines key developments in China’s antitrust sector for May. The following events merit special ...

Merck KGaA (Merck) is filing for global regulatory approvals of its CSF-1R inhibitor pimicotinib after it met the primary and all key secondary endpoints in a Phase III trial in tenosynovial giant ...

Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...

- Establishing High-quality Pharmaceutical Logistics Service Systems - ...

Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.